C5a-C5aR1 Axis Blockade in Patients With Severe COVID-19: Contrasting Results of PANAMO and FORCE – CIML

Recherche

Thème

Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

In Vitro Generation of Human Cross-Presenting Type 1 Conventional Dendritic Cells (cDC1s) and Plasmacytoid Dendritic Cells (pDCs).